Results 291 to 300 of about 380,167 (333)
EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial. [PDF]
TrialsSimon A +8 more
europepmc +1 more source
Impact of COVID-19 on Renal Transplant Recipients in a National Transplant Center. [PDF]
Immun Inflamm DisKoirala P +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1994
Renal transplantation is the treatment of choice for patients with end-stage renal disease. The authors present a rational approach to the pre-, intra-, and postoperative care required for successful patient management.
M, Suthanthiran, T B, Strom
openaire +4 more sources
Renal transplantation is the treatment of choice for patients with end-stage renal disease. The authors present a rational approach to the pre-, intra-, and postoperative care required for successful patient management.
M, Suthanthiran, T B, Strom
openaire +4 more sources
Seminars in Nephrology, 2001
Renal Transplantation has progressed from an experiment in surgery, nephrology, and immunology to the preferred means of renal replacement therapy for patients with end-stage renal disease. Patient and graft survival rates are spectacular in the short run and improving steadily in the long.
V, Ramanathan, S, Goral, J H, Helderman
openaire +2 more sources
Renal Transplantation has progressed from an experiment in surgery, nephrology, and immunology to the preferred means of renal replacement therapy for patients with end-stage renal disease. Patient and graft survival rates are spectacular in the short run and improving steadily in the long.
V, Ramanathan, S, Goral, J H, Helderman
openaire +2 more sources
Critical Care Clinics, 1990
Results of renal transplantation have markedly improved in the last decade. Patients previously defined as high risk (those aged greater than 50 years, infants, diabetics, and those with extra renal disease processes) can now be transplanted with excellent outcomes. Living related donors are preferred because of the improved success rates.
D J, Frey, A J, Matas
openaire +2 more sources
Results of renal transplantation have markedly improved in the last decade. Patients previously defined as high risk (those aged greater than 50 years, infants, diabetics, and those with extra renal disease processes) can now be transplanted with excellent outcomes. Living related donors are preferred because of the improved success rates.
D J, Frey, A J, Matas
openaire +2 more sources